Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

In winter, various respiratory infectious diseases such as influenza (flu), pneumonia, and COVID-19 are prevalent at the same ...

Roche’s cobas BV/CV assay gains CE Mark, enabling accurate, rapid diagnosis of bacterial vaginosis and candida vaginitis.

A further easing of animal movement restrictions has been announced for farms within the Bluetongue Virus (BTV) Temporary ...

WHO noted that prequalified tests can now be prioritized in pooled procurement mechanisms, which help lower prices, stabilize ...

Earlier this year the Therapeutic Goods Administration (TGA) halted the sale of 21 sunscreen products in Australia following ...

Scientists at Northwestern University have developed the fastest test yet for diagnosing hepatitis C virus (HCV). The highly ...

Roche’s cobas liat Bordetella test earns FDA clearance, delivering accurate whooping cough results in 15 minutes.

WHO said the decision builds on earlier emergency approvals and reflects the continued need for affordable, fast COVID-19 testing even after the pandemic’s emergency phase.

SGD Pharma has secured ISO 14021 certification for its PCR glass packaging in China, becoming the first glass manufacturer in ...

Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular ...

*The Co-Dx PCR platform (including the Co-Dx PCR Home (TM), Co-Dx PCR Pro (TM), mobile app, and all associated tests and software) is subject to review by the FDA and/or other regulatory bodies and is ...